Emicizumab is used in the treatment of hemophilia A.
How Emicizumab works In individuals with hemophilia A who have low or absent factor VIII, the blood coagulation process cannot proceed normally. Emicizumab functions as a bridge, connecting factor IXa and factor X to enable the blood coagulation process to continue without the need to replace factor VIII.
Common side effects of Emicizumab include injection site reactions (pain, swelling, redness), joint pain, and headache.
Emicizumab 30mg

₹48,040.3
MRP ₹55,218.8
Emicizumab 60mg

₹90,478.8
MRP ₹110,340
Emicizumab 150mg

₹294,392
Emicizumab 105mg

₹206,044